Search Results - Jibing Chen

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
    Bibliometric study and visual analysis of postoperative diabetes mellitus in kidney transplant recipients based on WoSCC database

    Bibliometric study and visual analysis of postoperative diabetes mellitus in kidney transplant recipients based on WoSCC database by Minhua Qiu, Sheng Chen, Jibing Chen, Hongjun Gao

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Exosomes and non-coding RNAs: bridging the gap in Alzheimer’s pathogenesis and therapeutics

    Exosomes and non-coding RNAs: bridging the gap in Alzheimer’s pathogenesis and therapeutics by Chunhui Guo, You Yanqiu, Jibing Chen, Ning Luo, Fujun Li

    Published 2025
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Hydrogen therapy can be used to control tumor progression and alleviate the adverse events of medications in patients with advanced non-small cell lung cancer

    Hydrogen therapy can be used to control tumor progression and alleviate the adverse events of medications in patients with advanced non-small cell lung cancer by Kecheng Xu, Jibing Chen, Xiaofeng Kong, Feng Mu, Tianyu Lu, Youyong Lu

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Pembrolizumab plus allogeneic NK cells in advanced non–small cell lung cancer patients

    Pembrolizumab plus allogeneic NK cells in advanced non–small cell lung cancer patients by Mao Lin, Haihua Luo, Shuzhen Liang, Jibing Chen, Aihua Liu, Lizhi Niu, Yong Jiang

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Integrating bulk and single-cell RNA sequencing reveals SH3D21 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway

    Integrating bulk and single-cell RNA sequencing reveals SH3D21 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway by Wangxia Tong, Na Qin, Tao Lu, Li Liu, Rong Liu, Jibing Chen, Ning Luo

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Cryoablation combined with allogenic natural killer cell immunotherapy improves the curative effect in patients with advanced hepatocellular cancer

    Cryoablation combined with allogenic natural killer cell immunotherapy improves the curative effect in patients with advanced hepatocellular cancer by Mao Lin, Shuzhen Liang, Xiaohua Wang, Yinqing Liang, Mingjie Zhang, Jibing Chen, Lizhi Niu, Kecheng Xu

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Comparison of autogeneic and allogeneic natural killer cells immunotherapy on the clinical outcome of recurrent breast cancer

    Comparison of autogeneic and allogeneic natural killer cells immunotherapy on the clinical outcome of recurrent breast cancer by Shuzhen Liang, Kecheng Xu, Lizhi Niu, Xiaohua Wang, Yingqing Liang, Mingjie Zhang, Jibing Chen, Mao Lin

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    “Real world survey” of hydrogen-controlled cancer: a follow-up report of 82 advanced cancer patients

    “Real world survey” of hydrogen-controlled cancer: a follow-up report of 82 advanced cancer patients by Kecheng Xu, Jibing Chen, Xiaofeng Kong, Youyong Lv, Shucun Qin, Xuejun Sun, Feng Mu, Tianyu Lu

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Single-cell sequencing reveals that AK5 inhibits apoptosis in AD oligodendrocytes by regulating the AMPK signaling pathway

    Single-cell sequencing reveals that AK5 inhibits apoptosis in AD oligodendrocytes by regulating the AMPK signaling pathway by Sizhong Yang, Boxiao Chen, Jiatong Zhang, Xiaoxia Zhou, Yuanjing Jiang, Wangxia Tong, Jibing Chen, Ning Luo

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Safety and Short-Term Efficacy of Irreversible Electroporation and Allogenic Natural Killer Cell Immunotherapy Combination in the Treatment of Patients with Unresectable Primary Liver Cancer

    Safety and Short-Term Efficacy of Irreversible Electroporation and Allogenic Natural Killer Cell Immunotherapy Combination in the Treatment of Patients with Unresectable Primary Li... by Yu-Mei Yang, Zilin Qin, Duanming Du, Yumin Wu, Shuibo Qiu, Feng Mu, Kengcheng Xu, Jibing Chen

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome

    Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome by Mohammed Alnaggar, Mao Lin, Adnan Mesmar, Shuzhen Liang, Ammar Qaid, Kecheng Xu, Jibing Chen, Lizhi Niu, Zhinan Yin

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic cancer patients

    Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic cancer patients by Mao Lin, Xiaoyan Zhang, Shuzhen Liang, Haihua Luo, Mohammed Alnaggar, Aihua Liu, Zhinan Yin, Jibing Chen, Lizhi Niu, Yong Jiang

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma

    Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma by Mohammed Alnaggar, Yan Xu, Jingxia Li, Junyi He, Jibing Chen, Man Li, Qingling Wu, Lin Li, Yingqing Liang, Xiaohua Wang, Jiawei Li, Yi Hu, Yan Chen, Kecheng Xu, Yangzhe Wu, Zhinan Yin

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer

    Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer by Yan Xu, Zheng Xiang, Mohammed Alnaggar, Léonce Kouakanou, Jiawei Li, Junyi He, Jiashuang Yang, Yi Hu, Yan Chen, Lin Li, Jianlei Hao, Jingxia Li, Jibing Chen, Man Li, Qingling Wu, Christian Peters, Qinghua Zhou, Jianshuang Li, Yingqing Liang, Xiaohua Wang, Baohui Han, Meili Ma, Dieter Kabelitz, Kecheng Xu, Wenwei Tu, Yangzhe Wu, Zhinan Yin

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: